chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I've had the Pfizer and Moderna. They suck. Covid sucks so much more though/ had side effects; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (I've had the Pfizer and Moderna. They suck. Covid sucks so much more though/ had side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (I've had the Pfizer and Moderna. They suck. Covid sucks so much more though/ had side effects). At the time of the report, IMMUNISATION REACTION (I've had the Pfizer and Moderna. They suck. Covid sucks so much more though/ had side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.   Reporter did not allow further contact
I received the Pfizer Bivalent booster on 10/3/2022. I began having the symptoms on 12/29/2022 that included fever, body aches, nasal congestion, and cough. On 12/30/2022, I took a rapid antigen and got a positive result. As of now, I have improved in the last 24 hours and am currently on Paxlovid.
This case was reported by a other health professional and described the occurrence of inappropriate age at vaccine administration in a 12-month-old female patient who received KINRIX (batch number 23MJ7, expiry date 22nd October 2015). On 5th December 2014, the patient received KINRIX. On 5th December 2014, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional information: MA reports inadvertent administration of KINRIX to a 12 month old.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from contactable consumer (patient) from a Pfizer-sponsored program Pfizer First Connect.  A 31-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE Batch/lot number: EK9231), via an unspecified route of administration in the left arm on 03Jan2021 at single dose for covid-19 immunisation. Medical history was none.  There were no concomitant medications. The patient tested positive for covid on 10Jan2021 with outcome of not recovered.
RECEIVED HALF DOSE FOR BOOSTER DOSE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 57 year old adult male with unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2. s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) unspecified manufacturer, dose not reported, 1 total administered for prophylactic vaccination (Dose number in series 1). It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809 or 211A21A and expiry: unknown) 0.25 ml, 1 total administered on 27-NOV-2021 for prophylactic vaccination (Dose number in series 2, Booster dose). No concomitant medications were reported.  On 27-NOV-2021, the patient received half dose for booster dose (Coded as Vaccine under dose and off label use). The reporter stated that something was printed and was disseminated which said to administer 0.25ml. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the received half dose for booster dose and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211202250, 20211201046, 20211201082, 20211201228, 20211201168, 20211200752, 20211202207, 20211200994, 20211201450, 20211201351, 20211202199, 20211202469, 20211201286, 20211204104, 20211202379, 20211201179, 20211201443, 20211220152, 20211220146, 20211220262, 20211220250, 20211220145, 20211220619, 20211219871 and 20211220155.
Case previously recorded as MA2009-4788. Report received on 23 NOV 2009 via agency from a healthcare professional the following information: Several children (details unknown) under the age of 4 were vaccinated i.m. with 0.5 ml FLUVIRIN, batch no. 102041P1 and 102044P1 on 20 NOV 2009. No adverse events were reported, no further information available. Company assessment: No serious criterion given. Causality: not applicable. Expectedness assessment according to foreign and local label: Vaccination with FLUVIRIN for children under 4 year is unexpected. No change in benefit-risk-ratio. No measures necessary. Agency no: NA09-008691.
tested positive; tested positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Feb2022) Positive, notes: grandson tested positive for COVID through a home kit in February.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This case was reported in a literature article and described the occurrence of uveitis in a 15-year-old female subject who was vaccinated with Hepatitis B (manufacturer unspecified). On an unspecified date the subject received unspecified dose of Hepatitis B (unknown). At an unspecified time after vaccination with Hepatitis B, the subject experienced uveitis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis B vaccine between 1982 and 2009. It appeared that all subjects recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Symptoms of abdominal pain, nausea, fever, headache, chills began evening of vaccine and proceeded to worsen over the next five days. On April 13 I saw my doctor who ordered blood work. The pain continued to worsen and on April 14 I was admitted to the hospital with a ruptured appendix and had surgery to remove it
Red circular rash appearance 6 days after injection. Warm & itchy. Application of topical hydrocortisone to area to relieve itching.
9/7/2022 was the first day of school and the first day patient started experiencing N/V. I would get cold by the school nurse 2 to 3 times a week every week since September 7 to come back and pick her up because she was vomiting in class.
acute mild edema to affected forearm with light bruising of unknown origin without known injury; acute mild edema to affected forearm with light bruising of unknown origin without known injury; unknown origin without known injury, tenderness to touch; Tennis elbow of opposite vaccine extremity around same time as vaccine, just after; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration in the right arm on 10Dec2020 in a hospital at a single dose for COVID vaccination. Medical history included anxiety and chronic migraines with aura. The patient has no known allergies. The patient was not pregnant at the time of vaccination, did not receive any other vaccine in four weeks, was not diagnosed with COVID prior to the vaccination, and was not tested for COVID post-vaccination. Concomitant medications included desvenlafaxine succinate (PRISTIQ), bupropion hydrochloride (WELLBUTRIN), and cyclobenzaprine. In Dec2020, the patient had tennis elbow of opposite vaccine extremity around the same time as the vaccine, just after. On 01Jan2021 at 04:00 AM, the patient experienced acute mild edema to affected forearm with light bruising of unknown origin without known injury, tenderness to touch. The patient did not receive any treatment for the events. It was reported that the events resulted in a doctor or other healthcare professional office/clinic visit. Outcome of the events was not recovered. The case was reported as non-serious (did not result in death, was not life-threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and did not result to any congenital anomaly/birth defect).  Information on the lot/batch number has been requested.
Information has been received from a physician concerning a 6 year old male who was vaccinated with a dose of varicella virus vaccine live. The physician reported that on 10/26/03 the pt developed chickenpox characterized by about 150 lesions. Unspecified medical attention was sought, but treatment was not required. At the time of this report, the pt was recovering with sequalae (unspecified).  The physician also reported that the pt's two brothers also developed chickenpox after being vaccinated with varicella virus vaccine live (WAES # 0311USA02058 & 0311USA02059).  Additional information has been requested.
Lump under my armpit the same arm where I got my shot at; It give me tingle all the way down my arm; Its like a paddy sack and its like very sore; Its like hard to open and close my arm; It still have a lymph node but they are excessively swollen on the one side; This is a spontaneous report from a contactable consumer (patient). A female patient of a 38-years-old received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 29Apr2021 (at the age of 37-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient received previously first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number EW0164), dose 1 via an unspecified route of administration on 08Apr2021 (at the age of 37-years-old) as DOSE 1, SINGLE for covid-19 immunisation and reported my first time was just sore. On an unspecified date, the patient reported that I had developed a lump under my armpit the same arm where I got my shot at. I am kind of figure out what should I do, I because its like a paddy sack and it was like very sore and its like hard to open and close my arm, It gave me tingle all the way down my arm. This was my first time, my first time was just sore the second was when I had the tingles and lump under my arm. Patient stated no, it was just an armpit issue, it still had a lymph nodes but they were excessively swollen on the one side. The patient received Tylenol, 500mg, taking 3 so its 1500, only taking twice a day. The outcome of the event was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I was submitting my events daily on website and two days it tells me my session has expired and won't let me report anything.  On Sunday night, March 21st, I started with very painful joint and muscle aches with fatigue.  The next morning I felt terrible and could barely function, I had a bought with diarrhea that lasted almost the entire day and had no energy.  I developed a large lump on my left clavicle area that seemed to be filled with fluid.  My knees I had replaced are still very painful today ( 7 days post vaccine).  I phoned my Dr. yesterday and they told me to take 1000mg of Tylenol 3 times a day.  I am doing this now for the second day with some relief.  I feel this is very unusual to feel this way 7 days after the vaccine.  On day 1-2 the only symptoms were a sore arm from the vaccine.  Saturday was actually a good day with no symptoms, the other symptoms started on Sunday.  I feel like my heartbeat is irregular also but my BP is good.  I would like to be able to to report daily on v-safe like I was the first few days.
Patient was seen at 8:45 a.m. on 08-29-2007 for a DAPTACEL REACTION. Pt came in on 08-29-2007 with a swollen right thigh. Child developed no fever according to father. Child was walking well and did not state any other discomforts.
Redness, swelling, inflammation. Visited Dr. Per patient MD prescribed KEFLEX 500 mg three times daily #21. (Per patient infection - according to MD).
6/6/21 PMHx of skeletal tuberculosis, hypothyroidism, hyperlipidemia, "frequent pneumonias", presented to ER w/worsening cough and diarrhea
It was reported that a 61 year old female patient received a Fluzone SV and a Pneumovax vaccination on 12/05/2000. Approximately 5 hours after vaccination, the patient developed general malaise, difficulty on expiration and stomach pain, which lasted approximately 40 hours and completely subsided.
No AE, but patient was given at age 17, and EUA is 18+.
Metalllic taste in mouth after 15 minutes; this went away after another 15 minutes.  Later that evening, I developed severe pain in the  right ankle, which went away by keeping weight off the ankle and was gone by the next day.  About 24 hours after the injection, I developed severe pain in my right knee, which went away after a few hours by icing it for about 20 minutes every hour.
constant throbbing pain at left shoulder, progressive limited left arm movement, and intermittent tingling and numbness at left hand.
flu; Initial information received on 30-Dec-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves Adult and unknown gender patient who had flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
Information has been received from a receptionist concerning her daughter who on an unspecified date was vaccinated with a first dose of Gardasil.  Subsequently, two days after the first dose the patient experienced psoriasis.  At the time of the report, the outcome was unknown.  Additional information has been requested.
Information has been received from a certified nurse midwife, for GARDASIL, a Pregnancy Registry Product, concerning a patient who was born at 37 weeks and 5 days of gestational age with no congenital anomaly. The birth weight was 4 pounds (lbs). The reporter considered the infant small for gestational age. The patient's mother, a 17 year old female, was vaccinated with the first dose of GARDASIL on 02-FEB-2009, the second dose on 04-MAY-2009 IM 0.5 ML right deltoid (lot#: 0151X). The mother's experience has been captured in WAES# 0905USA02012. Additional information has been requested.
Headache, Myalgia, Fever, NauseaVomiting, nasal drainage, injection site pain Narrative:  Employee reports experiencing injection site pain/discomfort, fever, headache, fatigue, body aches, nausea, and nasal drainage. Reported used Tylenol (unknown dose/frequency) for symptoms. Reports all symptoms have resolved as of date of report.
fever as high as 102.3 ( normal is 97.4), very red, swollen, arm with swelling, body aches, "cover headache", vomiting, lethargic,  Took Tylenol, applied ice initially to site, then alternate ice and heat, showers, bed rest, fluids took a full 48 to see I was feeling better....still today not 100%
Tiredness, chills, headache, nausea, began on sat night, then by sunady afternoon hives all over my body, feet, legs, thighs, bottom, back, chest, stomach, arms. These symptoms continued into Monday and Tuesday. The hives are burning and itchy.
Pulse rapid; Dizziness; Weakness; Feeling abnormal; Flu like symptoms; This is a spontaneous report from a contactable physician. A 65-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number and Expiration date was not reported) via intramuscular route of administration (age at vaccination 65-year) on 06Feb2021 as dose 1, single for COVID-19 immunization; adalimumab (HUMIRA) received via subcutaneous route of administration from Sep2018 (Batch/Lot number: Unknown) and ongoing, as 40 mg, 1 in 2 weeks for ankylosing spondylitis, rheumatoid arthritis. Medical history included alcoholism (Alcohol use occasionally, four to five glass of wines per week) from 1973 to an unknown date; tobacco use from 2002 to 2007; Premature Atrial Contractions and Penicillin Allergy Manifested by Tissue Swelling, both from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient experienced pulse rapid, dizziness and weakness on 07Feb2021; flu like symptoms and feeling abnormal in 2021. It was reported that in 2021, the patient experienced flu like symptoms and feeling like been run over by truck. On 07Feb2021, the patient experienced rapid heart rate, dizziness and weakness. On 12Apr2021, the patient experienced HUMIRA was not effective as before, joint pain and joint stiffness. In Apr2021, the rapid heart rate, dizziness and weakness resolved. COVID-19 Vaccine was also considered suspect. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. On 06Feb2021, patient COVID-19 Vaccine manufactured by Pfizer. On 05Mar2021, patient received 2nd dose COVID-19 Vaccine manufactured by Pfizer. Therapeutic measures were taken as a result of the adverse events, as reported the patient was treated with PREDNISONE. The action taken in response to the events for adalimumab was unknown. The clinical outcome of pulse rapid, dizziness and weakness, was recovered on an unspecified date in Apr2021, while the outcome of other events was not recovered.  Causality for HUMIRA 40MG/0.4ML(ADALIMUMAB): The reporter & as causality for the events of rapid heart rate, dizziness, HUMIRA was not effective as before, joint pain, flu like symptoms, weakness, joint stiffness and feeling like been run over by truck with HUMIRA 40MG/0.4ML(ADALIMUMAB) was a reasonable possibility.  Information on the lot/batch number has been requested.
Patient rec'd Pfizer Vaccine at site on 3/23/21 and was found unresponsive at home 4 hours later. Currently Hospitalized
This spontaneous report as received from a nurse refers to a 4 month old patient. The patient was vaccinated with 2 HIB vaccines concomitantly, a 0.5ml dose of LIQUID PEDVAXHIB and a dose of PENTACEL when while there for a 4 month check up. No other concomitant medications were reported. No adverse event reported. Additional information has been requested.
Patient received an H1N1 injection in left arm, and walked to observation seat, where he became pale and diaphoretic. He was placed on a mat in Trendelenburg position with legs elevated; and an ice pack was placed on posterior neck. His BP was 98/64 then. When his color improved, he was taken by wheelchair by the school nurse for recovery and his father was called.
This spontaneous report as received from a registered pharmacist refers to two or three patients of unknown age and gender. On an unknown date, the patients were vaccinated with 0.65 ml doses of ZOSTAVAX (lot # not reported) subcutaneously. The pharmacist reported that on an unknown date, within 24 hours of receiving ZOSTAVAX, the patients experienced itching at the injection site. The patients were informed by their unspecified physicians to take BENADRYL or apply a hydrocortisone (manufacturer unknown) cream to the injection site. At the time of the report, the patients had recovered a couple of days after receiving ZOSTAVAX. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of ACNE (Pimple outside of lip) and VACCINATION SITE PAIN (Pain at injection site) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. No Medical History information was reported. On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced ACNE (Pimple outside of lip) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, ACNE (Pimple outside of lip) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient reported 12 hours after immunization lip tingling, swelling, shortness of breath, body aches, diaphoresis, nasal congestion, and feeling of difficulty breathing.  Twelve hours after symptom onset patient presented to urgent care as symptoms were not resolving.  Vital signs within normal ranges except pulse 125 beats per minute and temperature 38.0 degrees Celsius. On exam, pharyngeal swelling and posterior oropharyngeal erythema were present. Diphenhydramine, prednisone, acetaminophen were administered with improvement in symptoms and vital signs. Patient monitored, continued to improve, and discharged home stable.